Tag: Anthos Therapeutics
Factor XI inhibitor ‘lives up to promise’ of reduced bleeding events...
Researchers from Mass General Brigham (Boston, USA) have evaluated a drug that represents a new class of anticoagulants known as Factor XI inhibitors for treating patients...